身体萌芽
发表于 2025-3-25 05:06:11
http://reply.papertrans.cn/83/8205/820492/820492_21.png
Processes
发表于 2025-3-25 08:32:15
http://reply.papertrans.cn/83/8205/820492/820492_22.png
AWL
发表于 2025-3-25 14:12:24
http://reply.papertrans.cn/83/8205/820492/820492_23.png
noxious
发表于 2025-3-25 18:12:57
http://reply.papertrans.cn/83/8205/820492/820492_24.png
legitimate
发表于 2025-3-25 23:17:11
http://reply.papertrans.cn/83/8205/820492/820492_25.png
可卡
发表于 2025-3-26 01:07:24
Radiation Therapy in the Management of Cutaneous T-Cell Lymphomas, Radiation therapy (RT) is an important palliative treatment modality in both advanced and localized cases. In this chapter, patients with advanced and early stage MF and pcALCL will be discussed. RT management in each of these cases will be addressed.
饰带
发表于 2025-3-26 05:23:55
Extranodal Marginal Zone Lymphoma,tic strategies, with a special focus on the role of radiotherapy. Current recommendations in terms of optimal dose, volumes, and techniques are also presented. Few tables summarize the results of the largest series reporting on the outcome following radiotherapy, and figures illustrate imaging features as well as contouring and planning examples.
清楚
发表于 2025-3-26 09:49:49
http://reply.papertrans.cn/83/8205/820492/820492_28.png
saturated-fat
发表于 2025-3-26 14:59:38
Extranodal Marginal Zone Lymphoma,ing virtually any organ, poses several challenges. The heterogeneity of the disease also explains the uncertainty and lack of consistency in radiotherapy approaches between centers and clinicians. EN-MZL often presents with localized/organ-confined disease, and RT is generally the primary curative m
悬崖
发表于 2025-3-26 17:36:48
Primary Mediastinal (Thymic) Large B-Cell Lymphoma,es that differ from diffuse large B-cell lymphoma (DLBCL). In the era of immunochemotherapy, a variety of chemotherapy regimens have been used for PMBL, including rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP); rituximab, methotrexate, leucovorin, doxorubicin, cycloph